Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Shield™ by Guardant blood-based screening test is now widely accessible for physician order through ...

The news comes one week after Boston-based Whoop announced broader plans to expand the business, including by increasing its staff by as much as 75 percent this year.

A DNA test could help match patients with psychiatric medications, potentially reducing the long and frustrating ...

The 164 positive tests the state has collected since last fall likely represent a fraction of the people exposed to high PFAS levels.

If you’re a Whoop member, you can expect to see two new women’s health updates for both hormonal insights and blood panels.

Rhythm Biosciences is entering a new commercial era, following the first sale of its revolutionary Colostat bowel cancer assay. ... Read More The post Health Check: Rhythm Biosciences is in the groove ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Two Melbourne entrepreneurs have raised money from members of the Myer family, with their biotech now valued at $90 million.

DelveInsight's Companion Diagnostics Market Insights report provides the current and forecast market analysis, individual leading companion diagnostics companies' market shares, challenges, companion ...

The growth of the companion diagnostics market is largely driven by the sharp worldwide rise in cancer incidence. Increasing awareness of precision medicine among patients, along with manufacturers' ...

Until this past January, few outside academic and diagnostic labs knew what quantitative reverse-transcription PCR (RT-qPCR) was, much less its role in viral and bacterial disease detection.